Dublin, Ireland

Opsona Therapeutics Limited

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 25.0


Forward Citations = 4

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Luke O'Neill (5 out of 11 patents)

silverMedal Christopher Phillip Locher (3 out of 5 patents)

bronzeMedal Mark Heffernan (3 out of 3 patents)

4.  Peter McGuirk (3 out of 3 patents)

5.  Brian Keogh (3 out of 5 patents)

6.  Fatih Arslan (1 out of 2 patents)

7.  Thorsten Hagemann (1 out of 1 patent)

8.  Nils Kuklik (1 out of 1 patent)

9.  Wolf-Dieter Schubert (1 out of 1 patent)

10.  Dominique De Kleijn (1 out of 1 patent)

11.  Gerard Pasterkamp (1 out of 1 patent)

12.  Jerome Dellacasagrande (1 out of 1 patent)

13.  Susan Carpenter (1 out of 1 patent)

14.  Aisling Dunne (1 out of 2 patents)

15.  Anne McGettrick (1 out of 1 patent)


8 patents:

Company Overview
Opsona Therapeutics is a biotechnology company focused on developing novel immunotherapies for the treatment of inflammatory and autoimmune diseases. With a strong pipeline of innovative drug candidates and a dedication to improving patient outcomes, Opsona is at the forefront of cutting-edge research in the field of immunotherapy.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

8 Patents

#122 in Dublin

#227 in Ireland

Dublin, IE
Dublin, Ireland
Forward Citations = 4

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Opsona Therapeutics Limited. Retrieved from https://idiyas.com/company/opsona-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…